Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Pamela Sater

Physician Assistant High Point, NC Physician Assistant

NPI 1245465657 CMS profile 10599954

1814 Westchester Dr, Suite 401, High Point, NC 27262

Open in the dashboard

General payments

$9,375

255 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Pamela Sater of High Point, NC is reported in the CMS Open Payments database as having received $9,375 across 255 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,343 63
2024 General $1,696 64
2023 General $4,117 99
2022 General $1,007 27
2021 General $212 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Pamela Sater
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Pamela Sater were reported at $2,343. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Pamela Sater Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $212 $132 $37–$438 $132
2022 $1,007 $155 $48–$522 $149
2023 $4,117 $167 $52–$557 $160
2024 $1,696 $178 $55–$600 $164
2025 $2,343 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Bayer HealthCare Pharmaceuticals Inc. $2,113 15 payments
  2. EMD Serono, Inc. $1,790 34 payments
  3. E.R. Squibb & Sons, L.L.C. $871 8 payments
  4. Alexion Pharmaceuticals, Inc. $672 16 payments
  5. UCB, Inc. $485 18 payments
  6. Biogen, Inc. $383 20 payments
  7. Jazz Pharmaceuticals Inc. $291 14 payments
  8. Genentech USA, Inc. $221 6 payments
  9. TG Therapeutics, Inc. $205 4 payments
  10. AbbVie, Inc. $203 11 payments
  11. Other $2,142 109 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $7,925 249 payments
  2. Travel and Lodging $1,450 6 payments
Products named General payments · program years 2021–2025
  1. ZEPOSIA $889 9 payments
  2. ULTOMIRIS $303 13 payments
  3. MAVENCLAD $238 7 payments
  4. BRIUMVI $205 4 payments
  5. Ocrevus Zunovo $201 5 payments
  6. Epidiolex $190 9 payments
  7. Hizentra $163 7 payments
  8. VYEPTI $159 7 payments
  9. ACTHAR $147 7 payments
  10. Rystiggo $141 4 payments
  11. Other $2,836 146 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

255 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record